RE-BVS – Piemonte Repository

Sfoglia per AUTORE
GIANNARELLI D
Collezione AOU Novara

Items : 5

Prediction of outcomes in chronic lymphocytic leukemia patients treated with ibrutinib: Validation of current prognostic models and development of a simplified three-factor model. in American journal of hematology / Am J Hematol. 2022 May;97(5):E176-E180. doi: 10.1002/ajh.26502. Epub 2022 Feb 25.

2022
AOU Città della Salute di Torino
AOU Novara

Trentin L; Foa' R; Cuneo A; Tedeschi A; Gaidano G; Coscia M; Guarente V; Noto A; Ielo C; Deodato M; Stelitano C; Del Poeta G; Giordano A; Levato L; Rigolin GM; Gentile M; Moia R; Murru R; De Paoli L; Laurenti L; Chiarenza A; Ciolli S; Vitale C; Frustaci AM; Mauro FR; Sportoletti P; Reda G; Visentin A; Giannarelli D; et alii...

Prognostic Impact and Risk Factors of Infections in Patients with Chronic Lymphocytic Leukemia Treated with Ibrutinib. in Cancers / Cancers (Basel). 2021 Jun 29;13(13):3240. doi: 10.3390/cancers13133240.

2021
AOU Città della Salute di Torino
AOU Novara

Foà R; Cuneo A; Gaidano G; Tedeschi A; Coscia M; Molica S; Noto A; Guarente V; Ielo C; Stelitano C; Del Poeta G; Giordano A; Levato L; Rigolin GM; Gentile M; Murru R; De Paoli L; Laurenti L; Vitale C; Chiarenza A; Ciolli S; Frustaci AM; Sportoletti P; Reda G; Visentin A; Giannarelli D; Mauro FR; Martelli M; Girmenia C; et alii...

Crizotinib in MET-Deregulated or ROS1-Rearranged Pretreated Non-Small Cell Lung Cancer (METROS): A Phase II, Prospective, Multicenter, Two-Arms Trial. in Clinical cancer research : an official journal of the American Association for Cancer Research / Clin Cancer Res. 2019 Dec 15;25(24):7312-7319. doi: 10.1158/1078-0432.CCR-19-0994. Epub 2019 Aug 15.

2019
AOU Novara

Landi L; Chiari R; Tiseo M; D'Incà F; Dazzi C; Chella A; Delmonte A; Bonanno L; Giannarelli D; Cortinovis DL; de Marinis F; Borra G; Morabito A; Gridelli C; Galetta D; Barbieri F; Grossi F; Capelletto E; Minuti G; Mazzoni F; Verusio C; Bria E; Alì G; Bruno R; Proietti A; Fontanini G; Crinò L; Cappuzzo F;

Low-dose alemtuzumab in refractory/relapsed chronic lymphocytic leukemia: Genetic profile and long-term outcome from a single center experience. in American journal of hematology / Am J Hematol. 2015 Nov;90(11):970-4. doi: 10.1002/ajh.24127. Epub 2015 Aug 14.

2015
AOU Novara

Sciumè M; Vincenti D; Reda G; Orofino N; Cassin R; Giannarelli D; Gaidano G; Rossi D; Cortelezzi A;

Bendamustine in combination with ofatumumab in relapsed or refractory chronic lymphocytic leukemia: a GIMEMA Multicenter Phase II Trial. in Leukemia / Leukemia. 2014 Mar;28(3):642-8. doi: 10.1038/leu.2013.334. Epub 2013 Nov 13.

2014
AOU Novara

Cortelezzi A; Sciumè M; Liberati AM; Vincenti D; Cuneo A; Reda G; Laurenti L; Zaja F; Marasca R; Chiarenza A; Gritti G; Orsucci L; Storti S; Angelucci E; Cascavilla N; Gobbi M; Mauro FR; Morabito F; Fabris S; Piciocchi A; Vignetti M; Neri A; Rossi D; Giannarelli D; Guarini A; Foà R;